Irene Groenveld

Irene Groenveld has a diverse work experience in the pharmaceutical industry, spanning over 15 years. Irene is currently the Head of Clinical Operations Oncology at Galapagos since December 2023. Prior to that, they served as the Head of Clinical Operations at CellPoint from July 2021 to December 2023. Irene also worked at Galapagos as a Clinical Operations Program Leader from September 2019 to July 2021, and as a Senior Clinical Study Manager from February 2018 to September 2019. Before joining Galapagos, they held the position of Senior Clinical Study Manager at Astellas Pharma from May 2011 to February 2018. Irene's experience also includes working as a Clinical Project Leader at AstraZeneca from May 2008 to May 2011, and as a Clinical Research Associate at Quintiles from September 2006 to April 2008. Overall, Irene Groenveld has demonstrated expertise in clinical operations and has held various leadership roles throughout their career.

Irene Groenveld completed their MSc in Pharmaceutical Science with a minor in Business at Utrecht University from 2000 to 2006. Prior to that, they attended Vrijzinnig Christelijk Lyceum from 1994 to 2000. There is no information available about their enrollment at the University of California, Berkeley.